CHPA 2004 Goals: Improving Switch Process, Launching Education Foundation
This article was originally published in The Tan Sheet
Executive Summary
A Consumer Healthcare Products Association "white paper" advising FDA on improving the Rx-to-OTC switch process is on the group's 2004 agenda for improving the regulatory environment for nonprescription drugs
You may also be interested in...
FDA Guidances On Actual Use Studies, Switches Will Clarify Agency Processes
A guidance on conducting actual use trials for Rx-to-OTC switch candidates is under development, according to FDA Office of New Drugs Director John Jenkins, MD
FDA Guidances On Actual Use Studies, Switches Will Clarify Agency Processes
A guidance on conducting actual use trials for Rx-to-OTC switch candidates is under development, according to FDA Office of New Drugs Director John Jenkins, MD
FDA Guidances On Actual Use Studies, Switches Will Clarify Agency Processes
A guidance on conducting actual use trials for Rx-to-OTC switch candidates is under development, according to FDA Office of New Drugs Director John Jenkins, MD